What is the primary purpose of this 10-K filing from Boston Scientific Corp. filed in March 1998?

The primary purpose of this 10-K filing is to provide a comprehensive annual report on Boston Scientific Corp.'s financial performance, operations, and business conditions for the fiscal year ending December 30, 1997. It is a mandatory filing for publicly traded companies with the U.S. Securities and Exchange Commission (SEC) and serves to inform investors and the public about the company's financial health, strategies, and potential risks.

What kind of financial information can an investor expect to find in this 1998 10-K for BSX?

Investors can expect to find detailed audited financial statements, including balance sheets, income statements, and cash flow statements, covering the fiscal year 1997. Additionally, the filing typically includes Management's Discussion and Analysis (MD&A) of financial condition and results of operations, as well as information on the company's business segments, legal proceedings, and risk factors relevant to its operations.

Given this filing is from 1998, what is its relevance to an investor today?

While this filing is historical, it provides crucial context for understanding Boston Scientific's long-term trajectory, its growth path in the medical device industry, and the foundations upon which its current business was built. Investors can analyze its past performance, strategic decisions, and market positioning to better evaluate the company's evolution, its resilience, and the sustainability of its business model over the decades.

What were the key business segments or product areas for Boston Scientific in 1997, as likely detailed in this report?

Based on Boston Scientific's known focus areas in the late 1990s, this 10-K would likely detail its operations in interventional cardiology, endoscopy, urology, and women's health, among other medical device specialties. The report would explain the performance and market dynamics of these segments, highlighting key products and growth drivers at that time.

BSX 10-K FY1997 Annual Report — Revenue, Net Income, EPS

Summary

This 10-K filing for Boston Scientific Corp. (BSX) for the period ending December 30, 1997, filed on March 31, 1998, represents a snapshot of the company's financial health and strategic positioning at a crucial time in its growth. As an investor, understanding the context of this filing is vital, as it precedes significant developments and showcases the company's foundational strengths and potential for future expansion within the medical device industry. The filing details the company's operations, financial performance, and risk factors, providing a basis for evaluating its investment merit. Investors should pay close attention to the detailed financial statements and management's discussion and analysis to understand the company's revenue streams, profitability, and any identified challenges. This report serves as a critical document for assessing the company's trajectory and its ability to navigate the competitive landscape of medical technology.

Key Highlights

1The filing pertains to the fiscal year ending December 30, 1997, submitted on March 31, 1998, providing historical financial data and company insights from that period.
2Boston Scientific Corporation (BSX) is the subject of this 10-K report, indicating its status as a publicly traded company required to disclose annual financial information.
3The filing includes detailed financial statements, management's discussion and analysis, and other critical disclosures necessary for investors to assess the company's performance and risks.
4This report would contain information on BSX's product lines, market position, and growth strategies within the medical device sector as of 1997.
5Investors can use this document to understand the company's financial health, revenue generation, and expenses during the reported fiscal year.
6The filing serves as a foundational document for evaluating BSX's historical performance and making informed investment decisions, particularly for understanding its early-stage growth drivers.

BOSTON SCIENTIFIC CORP Annual Report, Year Ended Dec 31, 1997

Summary

Key Highlights

Frequently Asked Questions